Implantable left ventricular assist devices and the kidney

Blood Purification

Volumn 37, Issue 1, 2014, Pages 57-66

  Mao, Huijuan ^a,b,c   Katz, Nevin ^d   Kim, Jeong Chul ^a,b   Day, Sonya ^a,b   Ronco, Claudio ^a,b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute Vicenza (IRRIV)   (Italy)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney; Left ventricular assist devices; Renal function

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; RENIN; TUMOR NECROSIS FACTOR ALPHA; WARFARIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BILIRUBIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NORADRENALIN;

ACUTE KIDNEY FAILURE; ALDOSTERONE BLOOD LEVEL; ANTICOAGULANT THERAPY; BLOOD PUMP; CARDIOGENIC SHOCK; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CREATININE CLEARANCE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTENSIVE CARE UNIT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; LEFT VENTRICULAR ASSIST DEVICE; MAGNETIC FIELD; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSATILE FLOW; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; ACUTE HEART INFARCTION; AORTA FLOW; ARTERY BLOOD FLOW; ASSISTED CIRCULATION; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CARDIORENAL SYNDROME; CATECHOLAMINE RELEASE; CENTRAL VENOUS PRESSURE; EXTRACORPOREAL CIRCULATION; FORWARD HEART FAILURE; HEART FUNCTION; HEART LEFT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; KIDNEY CIRCULATION; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PERFUSION; KIDNEY SIZE; MALNUTRITION; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PEAK SYSTOLIC VELOCITY; PERIARTERITIS; PREOPERATIVE EVALUATION; PRESSORECEPTOR; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RIGHT VENTRICULAR ASSIST DEVICE; RISK REDUCTION; SYMPATHETIC NERVE; TISSUE METABOLISM;

ACUTE KIDNEY INJURY; ANIMALS; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INCIDENCE; KIDNEY;

EID: 84893671452     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000357970     Document Type: Review

References (63)

1. Roger VL, Weston SA, Redfield MM, Heller-mann-Homan JP, Killian J, Yawn BP, Jacob-sen SJ: Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292:344-350.
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, La-zar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure Study G: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
3. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH: Heart-Mate II Investigators: advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251.
4. Cruz DN, Schmidt-Ott KM, Vescovo G, House AA, Kellum JA, Ronco C, McCullough PA: Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. Basel, Karger, 2013, vol 182, pp 117-136.
5. Mao H, Giuliani A, Blanca-Martos L, Kim JC, Nayak A, Virzi G, Brocca A, Scalzotto E, Neri M, Katz N, Ronco C: Effect of percutaneous ventricular assist devices on renal function. Blood Purif 2013; 35:119-266.
6. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS: Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 2012; 59: 26-36.
7. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV; HeartMate II Clinical Investigators: Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009; 120:2352-2357.
8. Sandner SE, Zimpfer D, Zrunek P, Dunkler D, Schima H, Rajek A, Grimm M, Wolner E, Wi-eselthaler GM: Renal function after implantation of continuous-versus pulsatile-flow left ventricular assist devices. J Heart Lung Transplant 2008; 27:469-473.
9. Butler J, Geisberg C, Howser R, Portner PM, Rogers JG, Deng MC, Pierson RN 3rd: Relationship between renal function and left ventricular assist device use. Ann Thorac Surg 2006; 81:1745-1751.
10. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH: Predictors of acute renal dysfunction after ventricular assist device placement. J Card Fail 2009; 15:874-881.
11. Topkara VK, Dang NC, Barili F, Cheema FH, Martens TP, George I, Bardakci H, Oz MC, Naka Y: Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant 2006; 25: 404-408.
12. Borgi J, Tsiouris A, Hodari A, Cogan CM, Paone G, Morgan JA: Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg 2013; 95: 163-169.
13. Lietz K, Miller LW: Patient selection for left-ventricular assist devices. Curr Opin Cardiol 2009; 24:246-251.
14. Lund LH, Matthews J, Aaronson K: Patient selection for left ventricular assist devices. Eur J Heart Fail 2010; 12:434-443.
15. James KB, McCarthy PM, Jaalouk S, Bravo EL, Betkowski A, Thomas JD, Nakatani S, Fouad-Tarazi FM: Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 1996; 93:1515-1519.
16. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Grimm M, Wolner E, Wieselthaler GM: Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009; 87:1072-1078.
17. Givertz MM: Cardiology patient pages: Ventricular assist devices. Important information for patients and families. Circulation 2011; 124:e305-e311.
18. Lietz K, Miller LW: Left ventricular assist devices: evolving devices and indications for use in ischemic heart disease. Curr Opin Cardiol 2004; 19:613-618.
19. Vural KM: Ventricular assist device applications. Anadolu Kardiyol Derg 2008; 8(suppl 2): 117-130.
20. Wakisaka Y, Taenaka Y, Chikanari K, Naka-tani T, Tatsumi E, Masuzawa T, Nishimura T, Takewa Y, Ohno T, Takano H: Long-term evaluation of a nonpulsatile mechanical circulatory support system. Artif Organs 1997; 21:639-644.
21. Travis AR, Giridharan GA, Pantalos GM, Dowling RD, Prabhu SD, Slaughter MS, So-bieski M, Undar A, Farrar DJ, Koenig SC: Vascular pulsatility in patients with a pulsatile-or continuous-flow ventricular assist device. J Thorac Cardiovasc Surg 2007; 133:517-524.
22. Amir O, Radovancevic B, Delgado RM 3rd, Kar B, Radovancevic R, Henderson M, Cohn WE, Smart FW: Peripheral vascular reactivity in patients with pulsatile vs. axial flow left ventricular assist device support. J Heart Lung Transplant 2006; 25:391-394.
23. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, Bravo E: Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 1995; 92:II191-II195.
24. Yambe T: Experimental study of renal sympathetic nerve activity during left ventricular assist device pumping. Sci Rep Res Inst Tohoku Univ Med 1990; 37:1-9.
25. Saito S, Westaby S, Piggot D, Dudnikov S, Robson D, Catarino PA, Clelland C, Nojiri C: End-organ function during chronic nonpul-satile circulation. Ann Thorac Surg 2002; 74: 1080-1085.
26. Nakano T, Tominaga R, Morita S, Masuda M, Nagano I, Imasaka K, Yasui H: Impacts of pulsatile systemic circulation on endotheli-um-derived nitric oxide release in anesthetized dogs. Ann Thorac Surg 2001; 72:156-162.
27. Bock JS, Gottlieb SS: Cardiorenal syndrome: new perspectives. Circulation 2010; 121: 2592-2600.
28. Sezai A, Shiono M, Orime Y, Nakata K, Hata M, Yamada H, Iida M, Kashiwazaki S, Kin-ishita J, Nemoto M, Koujima T, Sezai Y, Saitoh T: Renal circulation and cellular metabolism during left ventricular assisted circulation: comparison study of pulsatile and nonpulsatile assists. Artif Organs 1997; 21: 830-835.
29. Nemoto M: Experimental evaluation of the influence of complete artificial circulation on renal circulation and tissue metabolism-comparative study of pulsatile vs. nonpulsa-tile circulation. Ann Thorac Cardiovasc Surg 2003; 9:355-364.
30. Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, Toda K, Kawano Y, Naka-tani T: Effect of pulsatile left ventricular assist system implantation on Doppler measurements of renal hemodynamics in patients with advanced heart failure. Artif Organs 2012; 36:353-358.
31. Ootaki C, Yamashita M, Ootaki Y, Kamohara K, Weber S, Klatte RS, Smith WA, Massiello AL, Emancipator SN, Golding LA, Fukama-chi K: Reduced pulsatility induces periarteri-tis in kidney: role of the local renin-angioten-sin system. J Thorac Cardiovasc Surg 2008; 136:150-158.
32. Yambe T, Nitta S, Katahira Y, Sonobe T, Na-ganuma S, Akiho H, Chiba S, Kakinuma Y, Hayashi H, Tanaka M: Postganglionic sympathetic nerve activity with correlation to heart rhythm during left ventricular assistance. Ar-tif Organs 1991; 15:212-217.
33. Yambe T, Nitta S, Katahira Y, Sonobe T, Tanaka M, Miura M, Satoh N, Mohri H, Yo-shizawa M, Takeda H: Effect of left ventricular assistance on sympathetic tone. Int J Artif Organs 1990; 13:681-686.
34. Yambe T, Nitta S, Katahira Y, Sonobe T, Na-ganuma S, Akiho H, Chiba S, Kakinuma Y, Hayashi H, Izutsu K: Cardiac-related sympathetic nerve activity during circulation with only the left ventricular assist device. Int J Ar-tif Organs 1992; 15:49-54.
35. Nitta S, Yambe T, Katahira Y, Sonobe T, Na-ganuma S, Kakinuma Y, Tanaka M, Miura M, Sato N, Mohri H: Sympathetic nerve activity during maintaining circulation with only left ventricular assist device. Sci Rep Res Inst To-hoku Univ Med 1991; 38:51-56.
36. Nishimura T, Tatsumi E, Taenaka Y, Nishi-naka T, Nakatani T, Masuzawa T, Nakata M, Nakamura M, Endo S, Takano H: Effects of long-term nonpulsatile left heart bypass on the mechanical properties of the aortic wall. ASAIO J 1999; 45:455-459.
37. Kihara S, Litwak KN, Nichols L, Litwak P, Ka-meneva MV, Wu Z, Kormos RL, Griffith BP: Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 2003; 75: 178-183; discussion 183.
38. Yamagishi T, Oshima K, Hasegawa Y, Moha-ra J, Kanda T, Ishikawa S, Morishita Y: Cyto-kine induction by LVAD in the canine kidney. J Cardiovasc Surg (Torino) 2001; 42:759-768.
39. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Saito T, Daimon T, Ueno T, Kuratani T, Sawa Y: Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function. Circ J 2012; 76: 1631-1638.
40. Ma L, Fujino Y, Matsumiya G, Sawa Y, Mashi-mo T: Renal function with left ventricular assist devices: the poorer the preoperative renal function, the longer the recovery. Med Sci Monit 2008; 14:CR621-CR627.
41. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH: Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009; 28:827-833.
42. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, Gelijns AC, Hong KN, Teuteberg JJ: Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011; 30: 402-407.
43. Singh M, Shullo M, Kormos RL, Lockard K, Zomak R, Simon MA, Bermudez C, Bhama J, McNamara D, Toyoda Y, Teuteberg JJ: Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. Ann Thorac Surg 2011; 91:1348-1354.
44. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB: Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011; 30:115-123.
45. Khot UN, Mishra M, Yamani MH, Smedira NG, Paganini E, Yeager M, Buda T, McCarthy PM, Young JB, Starling RC: Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. J Am Coll Cardiol 2003; 41:381-385.
46. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, Committee ASA, Investigators: High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute de-compensated heart failure: a report from the adhere database. J Card Fail 2007; 13:422-430.
47. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109:1004-1009.
48. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA: Cardiorenal interactions: insights from the escape trial. J Am Coll Cardiol 2008; 51:1268-1274.
49. Kamdar F, Boyle A, Liao K, Colvin-Adams M, Joyce L, John R: Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 2009; 28: 352-359.
50. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R: Preoperative levels of bilirubin or creati-nine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J 2012; 77:96-104.
51. Yuan N, Arnaoutakis GJ, George TJ, Allen JG, Ju DG, Schaffer JM, Russell SD, Shah AS, Conte JV: The spectrum of complications following left ventricular assist device placement. J Card Surg 2012; 27:630-638.
52. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Bhama JK, Bermudez CA, Lockard KL, Winowich S, Kormos RL: Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant 2010; 29:981-988.
53. Parascandola SA, Pae WE Jr, Davis PK, Miller CA, Pierce WS, Waldhausen JA: Determinants of survival in patients with ventricular assist devices. ASAIO Trans 1988; 34:222-228.
54. Kaltenmaier B, Pommer W, Kaufmann F, Hennig E, Molzahn M, Hetzer R: Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO J 2000; 46:330-333.
55. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH: Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant 2011; 30:182-187.
56. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA: Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Tho-rac Surg 2010; 89: 1205-1209; discussion 1210.
57. Kanter KR, Swartz MT, Pennington DG, Ru-zevich SA, Madden M, McBride LR, Ter-muhlen DF: Renal failure in patients with ventricular assist devices. ASAIO Trans 1987; 33:426-428.
58. Akamatsu H, Arai H, Sakamoto T, Suzuki A: Effects of right ventricular failure on renal function during pneumatic left ventricular assist. Artif Organs 1996; 20:240-246.
59. Moreno SG, Novielli N, Cooper NJ: Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation. J Heart Lung Transplant 2012; 31:450-458.
60. Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH: Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA 2008; 300:2398-2406.
61. Rajagopalan N, Hoopes CW: Renal failure following ventricular assist device placement. J Am Coll Cardiol 2012; 59: 2220, author reply p 2220.
62. Kainuma S, Sakaguchi T, Saito S, Miyagawa S, Yoshikawa Y, Yamauchi T, Sakata Y, Taka-hashi A, Uehata T, Kuratani T, Sawa Y: Implantation of a Jarvik 2000 left ventricular assist device as a bridge to eligibility for refractory heart failure with renal dysfunction. J Artif Organs 2012; 15:83-86.
63. Elhenawy AM, Algarni KD, Rodger M, Maciver J, Maganti M, Cusimano RJ, Yau TM, Delgado DH, Ross HJ, Rao V: Mechanical circulatory support as a bridge to transplant candidacy. J Card Surg 2011; 26:542-547.